Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.

The Lennar-backed accommodation provider will take a Nasdaq listing having previously raised $530m, and was valued at $1.3bn as of June 2020.

The Tencent and SIG China-backed podcasting app developer, valued at $3.5bn three years ago, has filed for a US initial public offering.

The Taiho and UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

JD.com's logistics spinoff, which counts China Life and Tencent as investors, has received approval for an offering set to be between $3bn and $4bn in size.

The cybersecurity technology provider, which counts SB Isat among its early investors, has gone public in its home country.

GV, Tencent and Gilead Sciences will exit the vaccine and infectious disease drug developer in an initial public offering sized at about $110m.

Vaccitech, which developed the technology underlying Oxford’s covid vaccine, has priced its shares and will raise more than $110m in its IPO.

Desktop Metal is backing a $75m PIPE supporting the reverse takeover, which values the additive manufacturing technology provider at $410m.

The food ordering app developer's largest shareholder, Info Edge, is set to sell $100m of shares in the proposed dual offering.